Misoprostol (Cytotec) was originally developed for treating gastric ulcers. However, the drug is increasingly being given to women during labor in low- and middle-income countries to prevent postpartum hemorrhage (PPH). Although misoprostol is included on the World Health Organization's Essential Medicines List for this use, a study published in the Journal of the Royal Society of Medicine, states that there is insufficient evidence of the drugs effectiveness...
More...
More...